Matthew W. Borer, PhD Eli Lilly and Company

Dr. Matthew Borer obtained his Ph.D. in Analytical Chemistry from Indiana University, Bloomington. He has subsequently dedicated his career to pharmaceutical analytical chemistry, including expertise in areas such as reference standards, compendial affairs, method development, establishing control strategies, and technical leadership. Dr. Borer is currently the senior technical and strategic leader for the global reference standard program at Eli Lilly and Company. In this role, he is responsible for all corporate reference standard materials that support drug development and manufacturing. He also is a technical consultant for the Lilly Compendial Affairs department, building relationships with global pharmacopoeia agencies and developing technical strategies associated with compendial compliance. Dr. Borer is an active volunteer at the United States Pharmacopeia, currently serving as Chair of the 2015-2020 Biologics Expert Committee 4 - Antibiotics. Dr. Borer is also a member of the China National Institutes of Food and Drug Control National Drug Reference Standards Committee. He has been invited to speak at numerous global venues on a variety of analytical chemistry topics, including an emphasis on reference standards, compendial science and strategy, standardization of bioassay tests, and metal impurity testing.